TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33034180

Group type: EXPERIMENTAL
Intervention: Vacuum-gradient therapy combined with orthodontic correction (n=29)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Orthodontic correction alone (n=28)
Number of subjects: 57
Study: 35904769

Group type: EXPERIMENTAL
Intervention: Hypochlorous acid (HClO)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Povidone‐iodine (PVP‐I)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Isotonic saline
Number of subjects: 75
Study: 33887962

Group type: EXPERIMENTAL
Intervention: 12-week movement skill intervention
Number of subjects: 0
Study: 32847916

Group type: EXPERIMENTAL
Intervention: Reactive balance training (RBT) - one session
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Reactive balance training (RBT) - three sessions
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Reactive balance training (RBT) - six sessions
Number of subjects: 36

Group type: COMPARATOR
Intervention: Regular physiotherapy (control)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Falls and physical activity reporting
Number of subjects: 36
Study: 35106620

Group type: EXPERIMENTAL
Intervention: Zopiclone 7.5 mg at bedtime
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 34283647

Group type: EXPERIMENTAL
Intervention: 5 × 9 Gy SBRT regimen
Number of subjects: 20
Study: 34152878

Group type: EXPERIMENTAL
Intervention: Educational forgiveness intervention
Number of subjects: 21

Group type: COMPARATOR
Intervention: Psycho-education grief intervention with a humanistic approach
Number of subjects: 21
Study: 33093338

Group type: EXPERIMENTAL
Intervention: FIT Teens
Number of subjects: 40

Group type: COMPARATOR
Intervention: CBT
Number of subjects: 40
Study: 34971381

Group type: EXPERIMENTAL
Intervention: Enhanced implementation condition (with added patient tracking features and more implementation strategies)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Basic implementation condition (standard implementation)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both conditions (Enhanced and Basic)
Number of subjects: 14
Study: 34326048

Group type: EXPERIMENTAL
Intervention: 5% tea tree oil (TTO) gel
Number of subjects: 88

Group type: COMPARATOR
Intervention: 0.05% potassium permanganate (KMnO4) solution
Number of subjects: 88
Study: 32729405

Group type: EXPERIMENTAL
Intervention: Psychosocial stress situation (Trier Social Stress Test)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Neutral control task
Number of subjects: 47
Study: 35227369

Group type: EXPERIMENTAL
Intervention: Household chaos (HHchaos)
Number of subjects: 105
Study: 33122343

Group type: EXPERIMENTAL
Intervention: Lapatinib
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Afatinib
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Neratinib
Number of subjects: 11

Group type: COMPARATOR
Intervention: Trastuzumab and Pertuzumab (combined)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Neoadjuvant anti-HER2 therapy
Number of subjects: 11
Study: 35140313

Group type: EXPERIMENTAL
Intervention: 4000 IU of vitamin D3 taken daily
Number of subjects: 2423

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2423
Study: 34494901

Group type: EXPERIMENTAL
Intervention: Bridging reconstruction using dermal allograft
Number of subjects: 30

Group type: COMPARATOR
Intervention: Maximal repair
Number of subjects: 30
Study: 36093886

Group type: EXPERIMENTAL
Intervention: PEEP of 12 cmH2O with hourly ARMs (n=83)
Number of subjects: 162

Group type: COMPARATOR
Intervention: PEEP of 4 cmH2O (n=79)
Number of subjects: 162
Study: 35010394

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 34599139

Group type: EXPERIMENTAL
Intervention: venetoclax +LDAC
Number of subjects: 211

Group type: COMPARATOR
Intervention: placebo +LDAC
Number of subjects: 211
Study: 33393275

Group type: EXPERIMENTAL
Intervention: Provisional adhesive Maryland‐bridge (AMB) applied for 3 months
Number of subjects: 18

Group type: COMPARATOR
Intervention: No AMB (Control group)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: AMB
Number of subjects: 18

Group type: COMPARATOR
Intervention: AMB and Control (No AMB)
Number of subjects: 18
Study: 35124649

Group type: EXPERIMENTAL
Intervention: Computer-based cognitive training (CCT) with GRADIOR
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine daily care (Control Group)
Number of subjects: 0
Study: 33719708

Group type: EXPERIMENTAL
Intervention: 15-minute scripted introduction to AD forms (grade 7 reading level)
Number of subjects: 529

Group type: COMPARATOR
Intervention: Handing blank AD forms without explanation (Control)
Number of subjects: 529
Study: 35064366

Group type: EXPERIMENTAL
Intervention: Ibuprofen (400 mg) at 8 AM, 1 PM, and placebo at 8 PM
Number of subjects: 70

Group type: COMPARATOR
Intervention: Ibuprofen (400 mg) at 8 AM, 1 PM, and 8 PM (Control)
Number of subjects: 70
Study: 34085541

Group type: EXPERIMENTAL
Intervention: Hearing loss assessment in patients with type 2 diabetes
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Sensorineural hearing loss assessment
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Disabling hearing loss assessment
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Association of hearing loss with glycemic control
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Factors associated with hearing loss
Number of subjects: 157
Study: 34143404

Group type: EXPERIMENTAL
Intervention: Dissonance-based (DB) intervention
Number of subjects: 74

Group type: COMPARATOR
Intervention: Assessment-only control (AOC)
Number of subjects: 74
Study: 33789474

Group type: COMPARATOR
Intervention: Standard dressings
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Incisional negative pressure wound therapy (iNPWT)
Number of subjects: 462
Study: 35720911

Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (AE)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (Obese group)
Number of subjects: 36
Study: 34542190

Group type: EXPERIMENTAL
Intervention: Antioxidants and zinc combination
Number of subjects: 0
Study: 35272949

Group type: EXPERIMENTAL
Intervention: Immediate Carotid Endarterectomy (CEA)
Number of subjects: 3120

Group type: COMPARATOR
Intervention: Deferral of Carotid Endarterectomy (no intervention unless triggered)
Number of subjects: 3120
Study: 37919141

Group type: EXPERIMENTAL
Intervention: BNT162b2 (Comirnaty®, 30 µg)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: mRNA-1273 (Spikevax®, 100 µg)
Number of subjects: 53
Study: 33671217

Group type: EXPERIMENTAL
Intervention: Conventional (GC)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Self-ligating (GA)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Fixed multi-bracket low friction (GS)
Number of subjects: 90
Study: 32825189

Group type: EXPERIMENTAL
Intervention: Various dietary patterns (specific diets not detailed)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Classical and alternative methods of treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary interventions
Number of subjects: 0
Study: 36016478

Group type: EXPERIMENTAL
Intervention: Local ibuprofen (Odontocide)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Systemic ibuprofen (Ultracal + 200 mg ibuprofen)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (Ultracal)
Number of subjects: 90
Study: 36164019

Group type: EXPERIMENTAL
Intervention: P1101 (ropeginterferon Alfa-2b) administered subcutaneously every 2 weeks at starting dose of 250 mcg (Week 0), 350 mcg (Week 2), and target dose of 500 mcg (Week 4) for the remainder of the treatment period.
Number of subjects: 101

Group type: COMPARATOR
Intervention: Anagrelide (ANA) dosed according to local country label.
Number of subjects: 101
Study: 34058870

Group type: EXPERIMENTAL
Intervention: Robotic arm-assisted UKA
Number of subjects: 130

Group type: COMPARATOR
Intervention: Conventional manual UKA
Number of subjects: 130
Study: 36348617

Group type: EXPERIMENTAL
Intervention: Clade C regimen (adenovirus 26-based HIV-1 vaccine encoding 2 mosaic Gag and Pol, and 2 mosaic Env proteins plus adjuvanted clade C gp140)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Bivalent protein regimen (clade C regimen plus mosaic gp140)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study: 33635500

Group type: EXPERIMENTAL
Intervention: ICPA 2043
Number of subjects: 2

Group type: COMPARATOR
Intervention: ICPB 2043
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: qRT‐PCR assay
Number of subjects: 2
Study: 32859522

Group type: EXPERIMENTAL
Intervention: 60-min algorithm
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 90-min algorithm
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 120-min algorithm
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 150-min algorithm
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 180-min algorithm
Number of subjects: 19

Group type: COMPARATOR
Intervention: Self-report
Number of subjects: 19
Study: 35906532

Group type: EXPERIMENTAL
Intervention: Combined radiomics model using perivascular fat CT radiomics features and clinical risk factors
Number of subjects: 200
Study: 33135182

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (5 mg, once-yearly for 2 years)
Number of subjects: 656

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 656
Study: 32338233

Group type: EXPERIMENTAL
Intervention: Transcranial pulsed electromagnetic fields
Number of subjects: 84

Group type: COMPARATOR
Intervention: Methylphenidate immediate release
Number of subjects: 84
Study: 34897793

Group type: EXPERIMENTAL
Intervention: Matrix-adjusted estimating equations for the correlation parameters with a bias-corrected sandwich variance estimator
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Generalized estimating equations approach using model-based variance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Generalized estimating equations approach using sandwich variance with independence working correlation matrix
Number of subjects: 0
Study: 33612647

Group type: EXPERIMENTAL
Intervention: Body Mass Index (BMI)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Body Fat Percentage
Number of subjects: 16
Study: 35013548

Group type: EXPERIMENTAL
Intervention: Modest systemic hypothermia (33 C) for 48 hours
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard of care medical treatment
Number of subjects: 50
Study: 34323437

Group type: EXPERIMENTAL
Intervention: Percutaneous epidural lysis of adhesions
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 32245908

Group type: EXPERIMENTAL
Intervention: Endocuff Vision‐assisted BowelScope (EAB)
Number of subjects: 3222

Group type: COMPARATOR
Intervention: Standard BowelScope (SB)
Number of subjects: 3222
Study: 36307956

Group type: EXPERIMENTAL
Intervention: Moderate-protein diet with 25 g beef/d (B25, n=45)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High-protein diet with 150 g beef/d (B150, n=35)
Number of subjects: 80
Study: 34292206

Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Video-guided acupuncture imagery treatment (VGAIT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: VGAIT control
Number of subjects: 24
Study: 33156099

Group type: EXPERIMENTAL
Intervention: Engerix-B double dose
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Fendrix single dose
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 173
Study: 35120546

Group type: EXPERIMENTAL
Intervention: Robotic training with a multi-joint functional exoskeleton
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional physical therapy program
Number of subjects: 26
Study: 33602603

Group type: EXPERIMENTAL
Intervention: Biotène Moisturizing Spray (3 sprays)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Water spray (active control)
Number of subjects: 25
Study: 32179181

Group type: EXPERIMENTAL
Intervention: Self-sampling arm (vaginal self-sampling kit)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control arm (recommendations to have a Pap smear taken)
Number of subjects: 88
Study: 34231204

Group type: EXPERIMENTAL
Intervention: Supraclavicular approach
Number of subjects: 401

Group type: COMPARATOR
Intervention: Infraclavicular approach
Number of subjects: 401
Study: 34310874

Group type: EXPERIMENTAL
Intervention: Calcium electroporation (CaEP)
Number of subjects: 3486

Group type: EXPERIMENTAL
Intervention: Electrochemotherapy (ECT) with intravenous and intratumoral administration of bleomycin
Number of subjects: 3486

Group type: COMPARATOR
Intervention: Reversible and irreversible electroporation (control arm - group A)
Number of subjects: 3486

Group type: EXPERIMENTAL
Intervention: Overall survival (OS), body weight, pain level, and levels of biomarkers such as Ca 19-9
Number of subjects: 3486
Study: 33027362

Group type: EXPERIMENTAL
Intervention: Cefazolin (antibiotic group)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 124
Study: 35822425

Group type: EXPERIMENTAL
Intervention: ACE inhibitor (ACEi)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 48
Study: 32519208

Group type: EXPERIMENTAL
Intervention: First-generation antipsychotics
Number of subjects: 149

Group type: COMPARATOR
Intervention: Second-generation antipsychotics
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Doctors' assessments
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: PSP Scale
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Quality of life (SF-36)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Severity of disease (PANSS)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Level of sexual activities
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Well-being under treatment
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Cognitive changes
Number of subjects: 149
Study: 32361220

Group type: EXPERIMENTAL
Intervention: Lung-ultrasound monitoring
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (CXR and clinical findings)
Number of subjects: 88
Study: 35202468

Group type: EXPERIMENTAL
Intervention: Tandem Control‐IQ (CIQ) hybrid closed loop (HCL) system
Number of subjects: 49
Study: 33487503

Group type: EXPERIMENTAL
Intervention: Collagen protein hydrolysate + milk protein (CP+MP)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Milk protein (MP)
Number of subjects: 8
Study: 36170254

Group type: EXPERIMENTAL
Intervention: Stress sample (post-task)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Baseline sample (pre-task)
Number of subjects: 36
Study: 34495579

Group type: EXPERIMENTAL
Intervention: 5 g of fresh table grape per kg of body weight for 21 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Dietary recommendations only (Control)
Number of subjects: 40
Study: 37735383

Group type: EXPERIMENTAL
Intervention: Same-day discharge (G1)
Number of subjects: 72
Study: 33720637

Group type: EXPERIMENTAL
Intervention: Donanemab (700 mg for the first three doses and 1400 mg thereafter)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Donanemab
Number of subjects: 257
Study: 35241182

Group type: EXPERIMENTAL
Intervention: Brief cognitive therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: General form of CBT treatment
Number of subjects: 30
Study: 33814546

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 95

Group type: COMPARATOR
Intervention: Other antipsychotics
Number of subjects: 95
Study: 34251882

Group type: EXPERIMENTAL
Intervention: Early weightbearing (allowed weightbearing at 2 weeks postoperatively)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Early weightbearing
Number of subjects: 194

Group type: COMPARATOR
Intervention: Nonweightbearing (not allowed weightbearing until 6 weeks postoperatively)
Number of subjects: 194
Study: 32116155

Group type: EXPERIMENTAL
Intervention: NA1
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 36453313

Group type: EXPERIMENTAL
Intervention: Subconjunctival MMC injection at the end of trabeculectomy
Number of subjects: 40

Group type: COMPARATOR
Intervention: IntraTenon MMC injection before the initial conjunctival incision
Number of subjects: 40
Study: 34247604

Group type: EXPERIMENTAL
Intervention: Incentive Scheme intervention (conditional economic incentives and motivational interviewing)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 0
Study: 34624174

Group type: EXPERIMENTAL
Intervention: FDC tablets of macitentan/tadalafil (10/40 mg)
Number of subjects: 62
Study: 35151971

Group type: EXPERIMENTAL
Intervention: Amitriptyline (AMT) 25 mg every night
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Venlafaxine (VLF) 37.5 mg daily
Number of subjects: 80

Group type: COMPARATOR
Intervention: Amitriptyline (AMT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Venlafaxine (VLF)
Number of subjects: 80
Study: 33630912

Group type: EXPERIMENTAL
Intervention: Radiation therapy (RT)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Random forests (RF) machine learning algorithm
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Logistic regression (LR) analysis
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Retina fraction dose
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 101
Study: 32652491

Group type: EXPERIMENTAL
Intervention: High levels of mental fatigue (n = 30)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Low-moderate levels of mental fatigue (n = 25)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Mental fatigue
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Cortical thickness
Number of subjects: 55
Study: 35665493

Group type: EXPERIMENTAL
Intervention: Biofeedback assisted relaxation training (BART)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Distraction therapy
Number of subjects: 38
Study: 32053400

Group type: EXPERIMENTAL
Intervention: Trendelenburg position (TP)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Increased airway pressure (Paw) at 15, 20, 25, and 30 cmH2O
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Trendelenburg position (TP) during increasing Paw
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Post-liver resection
Number of subjects: 14
Study: 36309152

Group type: EXPERIMENTAL
Intervention: Surface guidance using AlignRT (procedure B)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Skin marks and tattoos (procedure A)
Number of subjects: 25
Study: 33084205

Group type: EXPERIMENTAL
Intervention: Natural bovine bone mineral covered with resorbable native collagen membrane (BBM/CM)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: PRGF alone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (spontaneous healing)
Number of subjects: 40
Study: 32171050

Group type: EXPERIMENTAL
Intervention: Wound care knowledge education
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Wound care skills training
Number of subjects: 36
Study: 34862248

Group type: COMPARATOR
Intervention: Pembrolizumab monotherapy (200 mg IV every 3 weeks)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Pembrolizumab + Acalabrutinib (100 mg orally twice daily)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Pembrolizumab + Acalabrutinib
Number of subjects: 76

Group type: COMPARATOR
Intervention: Pembrolizumab monotherapy
Number of subjects: 76
Study: 33297451

Group type: EXPERIMENTAL
Intervention: Trunk exercises on unstable surfaces
Number of subjects: 35

Group type: COMPARATOR
Intervention: Upper limb exercises (control group)
Number of subjects: 35
Study: 33555696

Group type: EXPERIMENTAL
Intervention: Nerve block and residual pain managed with opioids
Number of subjects: 60

Group type: COMPARATOR
Intervention: Opioids alone
Number of subjects: 60
Study: 32826406

Group type: EXPERIMENTAL
Intervention: Danish Whiplash Group Risk Assessment Score (DWGRAS)
Number of subjects: 927
Study: 34592684

Group type: EXPERIMENTAL
Intervention: 20 mg methylphenidate (N=13)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 200 mg caffeine (N=14)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 200 mg modafinil (N=12)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 32128549

Group type: EXPERIMENTAL
Intervention: IASTM using Graston instruments
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Roller massage stick
Number of subjects: 16
Study: 35617098

Group type: EXPERIMENTAL
Intervention: Nutrition education
Number of subjects: 126

Group type: COMPARATOR
Intervention: No nutrition education
Number of subjects: 126
Study: 34960013

Group type: EXPERIMENTAL
Intervention: Couples-based (CB) intervention
Number of subjects: 22

Group type: COMPARATOR
Intervention: Survivor-only (SO) intervention
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Couples-based (CB) intervention (spouses)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Survivor-only (SO) intervention (spouses)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Couples-based (CB) spouses vs Survivor-only (SO) spouses
Number of subjects: 22
Study: 34318542

Group type: EXPERIMENTAL
Intervention: Nurse-led telephone support with regular text messages and phone calls
Number of subjects: 77

Group type: COMPARATOR
Intervention: Usual hypertension care
Number of subjects: 77
Study: 34304669

Group type: EXPERIMENTAL
Intervention: Late preeclampsia group
Number of subjects: 160

Group type: COMPARATOR
Intervention: Healthy pregnant women group
Number of subjects: 160
Study: 32504715

Group type: EXPERIMENTAL
Intervention: Supine rehabilitation group (SRG)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Erect rehabilitation group (ERG)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both groups (SRG and ERG)
Number of subjects: 60
Study: 36134902

Group type: EXPERIMENTAL
Intervention: Denosumab (60 mg subcutaneously q6 months)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 30
Study: 34322673

Group type: EXPERIMENTAL
Intervention: Rifaximin 550 mg BID for 10 days
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 34903538

Group type: EXPERIMENTAL
Intervention: Chlorhexidine oral rinses (0.12%)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40